Prescription drug Febuxostat recalled due to manufacturing contamination
Sun Pharmaceutical is recalling 47,520 bottles of Febuxostat 40mg tablets nationwide due to microbial contamination found in manufacturing equipment. The FDA classified this as a Class II recall; no illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with microbial contamination in pharmaceutical manufacturing equipment. Per the rubric, risk-of-harm products without reported injury receive a High severity score. No illnesses have been reported.
Plain-English summary
Sun Pharmaceutical Industries Inc is recalling Febuxostat 40mg tablets manufactured and distributed under the NorthStarx brand. The recall affects 47,520 bottles with lot numbers DNE0865A and DNE0866A, expiring 06/30/2025, distributed nationwide.
The FDA issued a Class II recall after microbial contamination was identified in stagnant water within a duct of manufacturing equipment at the facility in Dadra, India. The contamination was discovered during current good manufacturing practice (CGMP) investigations.
No illnesses or injuries have been reported in connection with this product.
The recalled product
- Product
- FEBUXOSTAT (FEBUXOSTAT)
- Brand
- FEBUXOSTAT
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: DNE0865A
- DNE0866A
- Exp 06/30/2025
UPCs (1)
- 0316714060019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FEBUXOSTAT
- ModerateFebuxostat tablets recalled due to microbial contamination in manufacturing
FDA (Drugs) · 2024-03-20
- ModeratePrescription Drug Febuxostat Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2024-02-14
- ModerateFebuxostat Prescription Tablets Recalled Nationwide for Manufacturing Contamination
FDA (Drugs) · 2024-01-31
- HighFebuxostat 80 mg prescription tablets recalled for manufacturing contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27